Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Chemotherapy, Oregovomab, SBRT, and Nelfinavir in Pancreatic Cancer
NCT01959672Phase 2Completed
- Sponsor
- University of Nebraska
- Start
- Sep 2013
- Primary completion
- Apr 2018
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of oregovomab, nelfinavir in pancreatic adenocarcinoma (PDAC), sponsored by University of Nebraska. Started Sep 2013; status: completed.
02
Drugs
oregovomabnelfinavir
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01959672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01959672.